CollPlant Biotechnologies Ltd (CLGN) › Cost of RevenueCollPlant Biotechnologies Ltd (CLGN) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2018: $1.66M2019: $1.88M2020: $3.00M2021: $2.00M2022: $400.0K2023: $1.99M2024: $1.62M2025: $835.0K$835.0K2018Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$835.0K-48.6%2024$1.62M-18.4%2023$1.99M+397.8%2022$400.0K-80.0%2021$2.00M-33.2%2020$3.00M+59.8%2019$1.88M+13.3%2018$1.66M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share